{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:25:06Z","timestamp":1790461506347,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["RTI2018-098830-B-I00"],"award-info":[{"award-number":["RTI2018-098830-B-I00"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00345"],"award-info":[{"award-number":["PI20\/00345"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD21\/0017\/0031"],"award-info":[{"award-number":["RD21\/0017\/0031"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008425","name":"Xunta de Galicia Conseller\u00eda de Educacion e Ordenaci\u00f3n Universitaria","doi-asserted-by":"publisher","award":["ED431G\/05"],"award-info":[{"award-number":["ED431G\/05"]}],"id":[{"id":"10.13039\/501100008425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud y Familias, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015496","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bbi.2022.12.009","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T11:20:35Z","timestamp":1671189635000},"page":"255-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability"],"prefix":"10.1016","volume":"108","author":[{"given":"Maria A.","family":"Pedrosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen M.","family":"Labandeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aloia","family":"Quijano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00f1a","family":"Sanchez-Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Suarez-Quintanilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Lanciego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Labandeira-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Rodriguez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bbi.2022.12.009_b0005","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.4049\/jimmunol.177.8.5574","article-title":"IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program","volume":"177","author":"Argaw","year":"2006","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bbi.2022.12.009_b0010","doi-asserted-by":"crossref","first-page":"e12760","DOI":"10.1111\/nan.12760","article-title":"Impaired brain insulin signalling in Parkinson's disease","volume":"48","author":"Bassil","year":"2022","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/j.bbi.2022.12.009_b0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ijo.2009.199","article-title":"LIGHT is associated with hypertriglyceridemia in obese subjects and increased cytokine secretion from cultured human adipocytes","volume":"34","author":"Bassols","year":"2010","journal-title":"Int. J. Obes. Lond."},{"issue":"3","key":"10.1016\/j.bbi.2022.12.009_b0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.mam.2009.02.001","article-title":"Oxysterols and neurodegenerative diseases","volume":"30","author":"Bjorkhem","year":"2009","journal-title":"Mol. Aspects Med."},{"issue":"3","key":"10.1016\/j.bbi.2022.12.009_b0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/micc.12193","article-title":"Angiotensin and neurovascular coupling: beyond hypertension","volume":"22","author":"Bloch","year":"2015","journal-title":"Microcirculation"},{"key":"10.1016\/j.bbi.2022.12.009_b0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2741\/4707","article-title":"Loss of balance in normal GPCR-mediated cell trafficking","volume":"24","author":"Cabral-Marques","year":"2019","journal-title":"Front. Biosci. (Landmark Ed)"},{"issue":"10","key":"10.1016\/j.bbi.2022.12.009_b0035","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2174\/1389201019666180925121254","article-title":"The Role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeclampsia","volume":"19","author":"Campbell","year":"2018","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"6","key":"10.1016\/j.bbi.2022.12.009_b0040","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00281-020-00819-8","article-title":"Involvement of dopaminergic signaling in the cross talk between the renin-angiotensin system and inflammation","volume":"42","author":"Campos","year":"2020","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.bbi.2022.12.009_b0045","doi-asserted-by":"crossref","unstructured":"Chen, J., Guan, Z., Wang, L., Song, G., Ma, B., Wang, Y., 2014. Meta-analysis: overweight, obesity, and Parkinson's disease. Int. J. Endocrinol. 2014, 203930. https:\/\/doi.org\/10.1155\/2014\/203930.","DOI":"10.1155\/2014\/203930"},{"issue":"3\u20134","key":"10.1016\/j.bbi.2022.12.009_b0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000496977","article-title":"Association between Hypertension and the Risk of Parkinson's Disease: A Meta-Analysis of Analytical Studies","volume":"52","author":"Chen","year":"2019","journal-title":"Neuroepidemiology"},{"issue":"5","key":"10.1016\/j.bbi.2022.12.009_b0055","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.physbeh.2010.03.018","article-title":"The renin angiotensin system and the metabolic syndrome","volume":"100","author":"de Kloet","year":"2010","journal-title":"Physiol. Behav."},{"issue":"6","key":"10.1016\/j.bbi.2022.12.009_b0060","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","article-title":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism","volume":"64","author":"Deshotels","year":"2014","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.bbi.2022.12.009_b0065","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bbi.2022.12.009_b0070","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1159\/000360509","article-title":"Adipocyte cell death, fatty liver disease and associated metabolic disorders","volume":"32","author":"Eguchi","year":"2014","journal-title":"Dig Dis."},{"key":"10.1016\/j.bbi.2022.12.009_b0075","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fnins.2018.00196","article-title":"Metabolic Syndrome and Neuroprotection","volume":"12","author":"Etchegoyen","year":"2018","journal-title":"Front. Neurosci."},{"issue":"12","key":"10.1016\/j.bbi.2022.12.009_b0080","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1172\/JCI86950","article-title":"Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension","volume":"126","author":"Faraco","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bbi.2022.12.009_b0085","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/jcbfm.2008.158","article-title":"Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells","volume":"29","author":"Fleegal-DeMotta","year":"2009","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"7","key":"10.1016\/j.bbi.2022.12.009_b0095","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00004872-200018070-00017","article-title":"Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension","volume":"18","author":"Fu","year":"2000","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bbi.2022.12.009_b0100","doi-asserted-by":"crossref","unstructured":"F\u00fclber, I., Bacher, M., Dodel, R., R\u00f6skam, S., 2014. Evaluating the Murine Anti-Human Antibody Response and Assessment of General Activity and Cognition after Treatment with Human Intravenous Immunoglobulins in Healthy Adult C57\/B6J Mice. Eur. J. Inflamm. 12, 489-497. https:\/\/doi.org\/https:\/\/doi.org\/10.1177\/1721727X1401200310.","DOI":"10.1177\/1721727X1401200310"},{"issue":"2","key":"10.1016\/j.bbi.2022.12.009_b0105","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jhep.2020.04.001","article-title":"Lytic cell death in metabolic liver disease","volume":"73","author":"Gautheron","year":"2020","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.bbi.2022.12.009_b0110","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.bbrc.2007.09.043","article-title":"Angiotensin II protects against alpha-synuclein toxicity and reduces protein aggregation in vitro","volume":"363","author":"Grammatopoulos","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bbi.2022.12.009_b0115","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar4503","article-title":"Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients","volume":"16","author":"Gunther","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bbi.2022.12.009_b0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2015.12.018","article-title":"The control of tissue fibrosis by the inflammatory molecule LIGHT (TNF Superfamily member 14)","volume":"104","author":"Herro","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.bbi.2022.12.009_b0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.bbi.2022.12.009_b0130","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1212\/01.wnl.0000247052.18422.e5","article-title":"Body mass index and the risk of Parkinson disease","volume":"67","author":"Hu","year":"2006","journal-title":"Neurology"},{"issue":"21","key":"10.1016\/j.bbi.2022.12.009_b0135","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1212\/01.wnl.0000312511.62699.a8","article-title":"Total cholesterol and the risk of Parkinson disease","volume":"70","author":"Hu","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2022.12.009_b0140","doi-asserted-by":"crossref","unstructured":"Hu, G., 2010. Total cholesterol and the risk of Parkinson's disease: a review for some new findings. Parkinsons Dis. 2010, 836962. https:\/\/doi.org\/10.4061\/2010\/836962.","DOI":"10.4061\/2010\/836962"},{"issue":"3","key":"10.1016\/j.bbi.2022.12.009_b0145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bbrc.2019.12.111","article-title":"Telmisartan attenuates obesity-induced insulin resistance via suppression of AMPK mediated ER stress","volume":"523","author":"Huang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bbi.2022.12.009_b0150","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1161\/HYPERTENSIONAHA.110.150540","article-title":"Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling","volume":"55","author":"Irani","year":"2010","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.bbi.2022.12.009_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030876","article-title":"Within the Brain: The Renin Angiotensin System","volume":"19","author":"Jackson","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2022.12.009_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.837890","article-title":"Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson's Disease: A Nationwide Cohort Study","volume":"13","author":"Jo","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbi.2022.12.009_b0165","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1471-4159.2009.05999.x","article-title":"The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease","volume":"109","author":"Joglar","year":"2009","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.bbi.2022.12.009_b0170","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","article-title":"Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson's disease","volume":"25","author":"Kamath","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbi.2022.12.009_b0175","doi-asserted-by":"crossref","unstructured":"Kim, G.J., Mo, H., Liu, H., Wu, Z., Chen, S., Zheng, J., Zhao, X., Nucum, D., Shortland, J., Peng, L., Elepano, M., Tang, B., Olson, S., Paras, N., Li, H., Renslo, A.R., Arkin, M.R., Huang, B., Lu, B., Sirota, M., Guo, S., 2021. A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons. Elife. 10. https:\/\/doi.org\/10.7554\/eLife.69795.","DOI":"10.7554\/eLife.69795"},{"key":"10.1016\/j.bbi.2022.12.009_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2021.100914","article-title":"Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists","volume":"62","author":"Labandeira","year":"2021","journal-title":"Front. Neuroendocrinol."},{"issue":"8","key":"10.1016\/j.bbi.2022.12.009_b0185","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.4103\/1673-5374.332122","article-title":"Parkinson's disease and diabetes mellitus: common mechanisms and treatment repurposing","volume":"17","author":"Labandeira","year":"2022","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.bbi.2022.12.009_b0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41531-022-00340-9","article-title":"Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson s disease","volume":"8","author":"Labandeira","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"issue":"8","key":"10.1016\/j.bbi.2022.12.009_b0195","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/mds.29137","article-title":"Nigral Neurons Degenerating in Parkinson's Disease Express the Angiotensin Receptor Type 1 Gene","volume":"37","author":"Labandeira\u2010Garcia","year":"2022","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.bbi.2022.12.009_b0200","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/mds.25614","article-title":"Dopamine-angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease","volume":"28","author":"Labandeira-Garcia","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbi.2022.12.009_b0205","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnagi.2017.00129","article-title":"Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration","volume":"9","author":"Labandeira-Garcia","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbi.2022.12.009_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101919","article-title":"The intracellular renin-angiotensin system: Friend or foe. Some light from the dopaminergic neurons","volume":"199","author":"Labandeira-Garcia","year":"2021","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.bbi.2022.12.009_b0215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/IJICMR.S22329","article-title":"Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation","volume":"2011","author":"Lamarca","year":"2011","journal-title":"Int. J. Interferon Cytokine Mediat. Res."},{"issue":"34","key":"10.1016\/j.bbi.2022.12.009_b0220","doi-asserted-by":"crossref","first-page":"30113","DOI":"10.1074\/jbc.M505111200","article-title":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)","volume":"280","author":"Lambert","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.bbi.2022.12.009_b0225","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/WNL.0000000000004572","article-title":"Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores","volume":"89","author":"Leehey","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2022.12.009_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2022.04.029","article-title":"Association of angiotensin receptor blockers with incident Parkinson's disease in patients with hypertension: A retrospective cohort study","author":"Lin","year":"2022","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.bbi.2022.12.009_b0235","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/HYPERTENSIONAHA.113.02361","article-title":"Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification","volume":"63","author":"Liu","year":"2014","journal-title":"Hypertension."},{"issue":"12","key":"10.1016\/j.bbi.2022.12.009_b0240","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002323","article-title":"Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia","volume":"4","author":"Liu","year":"2015","journal-title":"J. Am. Heart Assoc."},{"issue":"8","key":"10.1016\/j.bbi.2022.12.009_b0245","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/ajh\/hpx027","article-title":"Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase","volume":"30","author":"Liu","year":"2017","journal-title":"Am. J. Hypertens."},{"issue":"5","key":"10.1016\/j.bbi.2022.12.009_b0250","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ajh\/hpz018","article-title":"Tissue Transglutaminase-Mediated AT1 Receptor Sensitization Underlies Pro-inflammatory Cytokine LIGHT-Induced Hypertension","volume":"32","author":"Liu","year":"2019","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bbi.2022.12.009_b0255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jsbmb.2019.03.003","article-title":"Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment","volume":"190","author":"Loera-Valencia","year":"2019","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.bbi.2022.12.009_b0260","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","article-title":"Mechanisms of Autoantibody-Induced Pathology","volume":"8","author":"Ludwig","year":"2017","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbi.2022.12.009_b0265","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3233\/JAD-2011-101512","article-title":"Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease","volume":"24","author":"Mateos","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbi.2022.12.009_b0270","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/978-1-4419-6612-4_56","article-title":"TNF: a key neuroinflammatory mediator of neurotoxicity and neurodegeneration in models of Parkinson's disease","volume":"691","author":"McCoy","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbi.2022.12.009_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.582166","article-title":"COVID-19-A Theory of Autoimmunity Against ACE-2 Explained","volume":"12","author":"McMillan","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bbi.2022.12.009_b0280","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/a-1120-8647","article-title":"Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism","volume":"52","author":"Meyer","year":"2020","journal-title":"Horm. Metab. Res."},{"issue":"4","key":"10.1016\/j.bbi.2022.12.009_b0285","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/08916934.2021.1916915","article-title":"The prevalence and role of functional autoantibodies to angiotensin-converting-enzyme-2 in patients with systemic sclerosis","volume":"54","author":"Miziolek","year":"2021","journal-title":"Autoimmunity"},{"key":"10.1016\/j.bbi.2022.12.009_b0290","doi-asserted-by":"crossref","unstructured":"Nam, G.E., Kim, S.M., Han, K., Kim, N.H., Chung, H.S., Kim, J.W., Han, B., Cho, S.J., Yu, J.H., Park, Y.G., Choi, K.M., 2018. Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study. PLoS Med. 15 (8), e1002640. https:\/\/doi.org\/10.1371\/journal.pmed.1002640.","DOI":"10.1371\/journal.pmed.1002640"},{"issue":"2","key":"10.1016\/j.bbi.2022.12.009_b0295","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/08830185.2019.1711073","article-title":"Decoding intrathecal immunoglobulins and B cells in the CNS: their synthesis, function, and regulation","volume":"39","author":"Negi","year":"2020","journal-title":"Int. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.bbi.2022.12.009_b0300","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3233\/JPD-212589","article-title":"Association of Dynamic Changes in Metabolic Syndrome Status with the Risk of Parkinson's Disease: A Nationwide Cohort Study","volume":"11","author":"Park","year":"2021","journal-title":"J. Parkinsons Dis."},{"issue":"16","key":"10.1016\/j.bbi.2022.12.009_b0305","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1111\/bph.15353","article-title":"Sex difference in flux of 27-hydroxycholesterol into the brain","volume":"178","author":"Parrado-Fernandez","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbi.2022.12.009_b0310","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/CS20201511","article-title":"Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19","volume":"135","author":"Pedrosa","year":"2021","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.bbi.2022.12.009_b0315","doi-asserted-by":"crossref","unstructured":"Pettersson, U.S., Walden, T.B., Carlsson, P.O., Jansson, L., Phillipson, M., 2012. Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue. PLoS One. 7 (9), e46057. https:\/\/doi.org\/10.1371\/journal.pone.0046057.","DOI":"10.1371\/journal.pone.0046057"},{"issue":"5","key":"10.1016\/j.bbi.2022.12.009_b0320","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.bbadis.2016.04.017","article-title":"Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease","volume":"1863","author":"Pugazhenthi","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bbi.2022.12.009_b0325","series-title":"R: a language and environment for statistical computing","year":"2020"},{"issue":"5","key":"10.1016\/j.bbi.2022.12.009_b0330","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbadis.2016.07.019","article-title":"The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance","volume":"1863","author":"Ramalingam","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"4","key":"10.1016\/j.bbi.2022.12.009_b0335","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1042\/BST20140319","article-title":"The blood-brain barrier endothelium: a target for pro-inflammatory cytokines","volume":"43","author":"Rochfort","year":"2015","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.bbi.2022.12.009_b0340","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.nbd.2008.03.003","article-title":"Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS","volume":"31","author":"Rodriguez-Pallares","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.bbi.2022.12.009_b0345","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s13311-018-0646-z","article-title":"Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death","volume":"15","author":"Rodriguez-Perez","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbi.2022.12.009_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102683","article-title":"Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19","volume":"122","author":"Rodriguez-Perez","year":"2021","journal-title":"J. Autoimmun."},{"issue":"10","key":"10.1016\/j.bbi.2022.12.009_b0355","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.parkreldis.2015.07.017","article-title":"Prospective study on the components of metabolic syndrome and the incidence of Parkinson's disease","volume":"21","author":"Saaksjarvi","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"9","key":"10.1016\/j.bbi.2022.12.009_b0360","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.4103\/1673-5374.165208","article-title":"Neuroinflammation and comorbidities are frequently ignored factors in CNS pathology","volume":"10","author":"Sandu","year":"2015","journal-title":"Neural. Regen. Res."},{"issue":"3","key":"10.1016\/j.bbi.2022.12.009_b0365","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1161\/HYPERTENSIONAHA.120.15581","article-title":"Endothelium-Macrophage Crosstalk Mediates Blood-Brain Barrier Dysfunction in Hypertension","volume":"76","author":"Santisteban","year":"2020","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.bbi.2022.12.009_b0370","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.12.051","article-title":"Telmisartan reduces progressive oxidative stress and phosphorylated alpha-synuclein accumulation in stroke-resistant spontaneously hypertensive rats after transient middle cerebral artery occlusion","volume":"23","author":"Sato","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"1","key":"10.1016\/j.bbi.2022.12.009_b0375","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/imcb.1002","article-title":"Shining LIGHT on the metabolic role of the cytokine TNFSF14 and the implications on hepatic IL-6 production","volume":"96","author":"Saunders","year":"2018","journal-title":"Immunol. Cell Biol."},{"issue":"11","key":"10.1016\/j.bbi.2022.12.009_b0380","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00424-018-2178-0","article-title":"Telmisartan prevents diet-induced obesity and preserves leptin transport across the blood-brain barrier in high-fat diet-fed mice","volume":"470","author":"Schuster","year":"2018","journal-title":"Pflugers Arch."},{"issue":"3","key":"10.1016\/j.bbi.2022.12.009_b0385","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1113\/EP086434","article-title":"The role of the blood-brain barrier in hypertension","volume":"103","author":"Setiadi","year":"2018","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.bbi.2022.12.009_b0390","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fendo.2014.00023","article-title":"Tissue Renin-Angiotensin systems: a unifying hypothesis of metabolic disease","volume":"5","author":"Skov","year":"2014","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"9","key":"10.1016\/j.bbi.2022.12.009_b0395","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41582-020-0381-z","article-title":"The B cell immunobiology that underlies CNS autoantibody-mediated diseases","volume":"16","author":"Sun","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.bbi.2022.12.009_b0400","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/ar3012","article-title":"Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases","volume":"12","author":"Takahashi","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.bbi.2022.12.009_b0405","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1530\/EC-20-0569","article-title":"Association of metabolic syndrome components with circulating levels of cytokine clusters in young women","volume":"10","author":"Tan","year":"2021","journal-title":"Endocr. Connect."},{"issue":"11","key":"10.1016\/j.bbi.2022.12.009_b0410","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbi.2022.12.009_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110043","article-title":"Autoimmunity to ACE2 as a possible cause of tissue inflammation in Covid-19","volume":"144","author":"Townsend","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"4","key":"10.1016\/j.bbi.2022.12.009_b0420","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1002\/ctm2.371","article-title":"Interactions between ibuprofen, ACE2, renin-angiotensin system, and spike protein in the lung. Implications for COVID-19","volume":"11","author":"Valenzuela","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbi.2022.12.009_b0425","doi-asserted-by":"crossref","unstructured":"Villar-Cheda, B., Costa-Besada, M.A., Valenzuela, R., Perez-Costas, E., Melendez-Ferro, M., Labandeira-Garcia, J.L., 2017. The intracellular angiotensin system buffers deleterious effects of the extracellular paracrine system. Cell Death Dis. 8 (9), e3044. https:\/\/doi.org\/10.1038\/cddis.2017.439.","DOI":"10.1038\/cddis.2017.439"},{"issue":"7","key":"10.1016\/j.bbi.2022.12.009_b0430","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI4106","article-title":"Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor","volume":"103","author":"Wallukat","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bbi.2022.12.009_b0435","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3233\/JAD-181035","article-title":"Contributions by the Brain Renin-Angiotensin System to Memory, Cognition, and Alzheimer's Disease","volume":"67","author":"Wright","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.bbi.2022.12.009_b0440","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCRESAHA.116.310509","article-title":"Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension","volume":"121","author":"Xu","year":"2017","journal-title":"Circ. Res."},{"issue":"24","key":"10.1016\/j.bbi.2022.12.009_b0445","doi-asserted-by":"crossref","first-page":"e20674","DOI":"10.1097\/MD.0000000000020674","article-title":"The efficacy of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on insulin resistance in hypertensive patients: A protocol for a systematic review and meta-analysis","volume":"99","author":"Yao","year":"2020","journal-title":"Medicine (Baltimore)."},{"issue":"6","key":"10.1016\/j.bbi.2022.12.009_b0450","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41419-018-0739-y","article-title":"Dapsone protects brain microvascular integrity from high-fat diet induced LDL oxidation","volume":"9","author":"Zhan","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbi.2022.12.009_b0455","doi-asserted-by":"crossref","unstructured":"Zhang, P., Tian, B., 2014. Metabolic syndrome: an important risk factor for Parkinson's disease. Oxid. Med .Cell Longev. 2014, 729194. https:\/\/doi.org\/10.1155\/2014\/729194.","DOI":"10.1155\/2014\/729194"},{"issue":"5","key":"10.1016\/j.bbi.2022.12.009_b0460","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1358863X12450094","article-title":"Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease","volume":"17","author":"Zhou","year":"2012","journal-title":"Vasc. Med."},{"issue":"8","key":"10.1016\/j.bbi.2022.12.009_b0465","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nm.1856","article-title":"Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice","volume":"14","author":"Zhou","year":"2008","journal-title":"Nat. Med."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159122004676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159122004676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:22:36Z","timestamp":1760170956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159122004676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":92,"alternative-id":["S0889159122004676"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2022.12.009","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2022.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}